North America Ophthalmic Drug Delivery System Market 2022-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity
- Report ID: 43047
- Date: Aug, 2022
- Pages: 116
- Category: Healthcare & Pharmaceuticals
North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 20 tables and 53 figures, this 116-page report “North America Ophthalmic Drug Delivery System Market 2022-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2022 and provides forecast from 2022 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pre-filled Syringes
• Multidose Eyedroppers
• Squeeze Dispensers
• Mist Sprayers
• Contact Lenses
• Ocular Inserts
• Intraocular Implants
• Punctal Plugs
• Other Products
Based on Dosage Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Solutions
• Gels
• Ointments
• Suspensions
• Emulsions
• Liposomes & Nanoparticles
By Disease, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Glaucoma
• Diabetic Retinopathy
• Cataract
• Dry Eye Syndrome
• Macular Degeneration
• Diabetic Macular Edema
• Refractive Issues
• Other Diseases
By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Other Settings
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aero Pump GmbH
Allergan plc.
AptarGroup, Inc.
Becton, Dickinson and Company
Biocorp
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer AG
Jotteq Inc.
Kedalion Therapeutics, Inc.
Mati Therapeutics, Inc.
Nemera
Nipro Corporation
Ocular Therapeutix, Inc.
Ocumedic, Inc.
Owen Mumford
Re-Vana Therapeutics
Silgan Holdings Inc.
Terumo Corporation
Valeant Pharmaceuticals International Inc. (Bausch Health Company)
West Pharmaceutical Services, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Product 40
3.1 Market Overview by Product 40
3.2 Pre-filled Syringes 42
3.3 Multidose Eyedroppers 43
3.4 Squeeze Dispensers 44
3.5 Mist Sprayers 45
3.6 Contact Lenses 46
3.7 Ocular Inserts 47
3.8 Intraocular Implants 48
3.9 Punctal Plugs 49
3.10 Other Products 50
4 Segmentation of North America Market by Dosage Form 51
4.1 Market Overview by Dosage Form 51
4.2 Solutions 53
4.3 Gels 54
4.4 Ointments 55
4.5 Suspensions 56
4.6 Emulsions 57
4.7 Liposomes & Nanoparticles 58
5 Segmentation of North America Market by Disease 59
5.1 Market Overview by Disease 59
5.2 Glaucoma 61
5.3 Diabetic Retinopathy 62
5.4 Cataract 63
5.5 Dry Eye Syndrome 64
5.6 Macular Degeneration 65
5.7 Diabetic Macular Edema 66
5.8 Refractive Issues 67
5.9 Other Diseases 68
6 Segmentation of North America Market by Setting 69
6.1 Market Overview by Setting 69
6.2 Hospitals 71
6.3 Clinics 72
6.4 Homecare Settings 73
6.5 Ambulatory Surgical Centers (ASCs) 74
6.6 Other Settings 75
7 North America Market 2021-2031 by Country 76
7.1 Overview of North America Market 76
7.2 U.S. 79
7.3 Canada 83
7.4 Mexico 86
8 Competitive Landscape 89
8.1 Overview of Key Vendors 89
8.2 New Product Launch, Partnership, Investment, and M&A 92
8.3 Company Profiles 93
Aero Pump GmbH 93
Allergan plc. 95
AptarGroup, Inc. 96
Becton, Dickinson and Company 97
Biocorp 98
Clearside Biomedical, Inc. 99
EyePoint Pharmaceuticals, Inc. 100
Gaplast GmbH 101
Gerresheimer AG 102
Jotteq Inc. 103
Kedalion Therapeutics, Inc. 104
Mati Therapeutics, Inc. 105
Nemera 106
Nipro Corporation 107
Ocular Therapeutix, Inc. 108
Ocumedic, Inc. 109
Owen Mumford 110
Re-Vana Therapeutics 111
Silgan Holdings Inc. 112
Terumo Corporation 113
Valeant Pharmaceuticals International Inc. (Bausch Health Company) 114
West Pharmaceutical Services, Inc. 115
RELATED REPORTS 116
List of Tables
Table 1. Snapshot of North America Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Main Product Trends and Market Opportunities in North America Ophthalmic Drug Delivery System Market 32
Table 4. North America Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 40
Table 5. North America Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 51
Table 6. North America Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 59
Table 7. North America Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 69
Table 8. North America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 77
Table 9. U.S. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 81
Table 10. U.S. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 81
Table 11. U.S. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 82
Table 12. Canada Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 84
Table 13. Canada Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 84
Table 14. Canada Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 85
Table 15. Mexico Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 87
Table 16. Mexico Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 87
Table 17. Mexico Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 88
Table 18. Aero Pump GmbH: Company Snapshot 93
Table 19. Aero Pump GmbH: Business Segmentation 94
Table 20. Aero Pump GmbH: Product Portfolio 94
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Industry Value Chain Analysis 19
Figure 5. North America Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of North America Ophthalmic Drug Delivery System Market 25
Figure 8. Number of Population Affected by Vision Impairment, All Ages by Sex, 1990–2050F 28
Figure 9. Primary Restraints and Impact Factors of North America Ophthalmic Drug Delivery System Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Ophthalmic Drug Delivery System Market 36
Figure 12. Breakdown of North America Ophthalmic Drug Delivery System Market by Product, 2021-2031, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 41
Figure 14. North America Ophthalmic Drug Delivery System Market by Product: Pre-filled Syringes, 2021-2031, $ mn 42
Figure 15. North America Ophthalmic Drug Delivery System Market by Product: Multidose Eyedroppers, 2021-2031, $ mn 43
Figure 16. North America Ophthalmic Drug Delivery System Market by Product: Squeeze Dispensers, 2021-2031, $ mn 44
Figure 17. North America Ophthalmic Drug Delivery System Market by Product: Mist Sprayers, 2021-2031, $ mn 45
Figure 18. North America Ophthalmic Drug Delivery System Market by Product: Contact Lenses, 2021-2031, $ mn 46
Figure 19. North America Ophthalmic Drug Delivery System Market by Product: Ocular Inserts, 2021-2031, $ mn 47
Figure 20. North America Ophthalmic Drug Delivery System Market by Product: Intraocular Implants, 2021-2031, $ mn 48
Figure 21. North America Ophthalmic Drug Delivery System Market by Product: Punctal Plugs, 2021-2031, $ mn 49
Figure 22. North America Ophthalmic Drug Delivery System Market by Product: Other Products, 2021-2031, $ mn 50
Figure 23. Breakdown of North America Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, % of Sales Revenue 52
Figure 24. North America Addressable Market Cap in 2022-2031 by Dosage Form, Value ($ mn) and Share (%) 52
Figure 25. North America Ophthalmic Drug Delivery System Market by Dosage Form: Solutions, 2021-2031, $ mn 53
Figure 26. North America Ophthalmic Drug Delivery System Market by Dosage Form: Gels, 2021-2031, $ mn 54
Figure 27. North America Ophthalmic Drug Delivery System Market by Dosage Form: Ointments, 2021-2031, $ mn 55
Figure 28. North America Ophthalmic Drug Delivery System Market by Dosage Form: Suspensions, 2021-2031, $ mn 56
Figure 29. North America Ophthalmic Drug Delivery System Market by Dosage Form: Emulsions, 2021-2031, $ mn 57
Figure 30. North America Ophthalmic Drug Delivery System Market by Dosage Form: Liposomes & Nanoparticles, 2021-2031, $ mn 58
Figure 31. Breakdown of North America Ophthalmic Drug Delivery System Market by Disease, 2021-2031, % of Sales Revenue 60
Figure 32. North America Addressable Market Cap in 2022-2031 by Disease, Value ($ mn) and Share (%) 60
Figure 33. North America Ophthalmic Drug Delivery System Market by Disease: Glaucoma, 2021-2031, $ mn 61
Figure 34. North America Ophthalmic Drug Delivery System Market by Disease: Diabetic Retinopathy, 2021-2031, $ mn 62
Figure 35. North America Ophthalmic Drug Delivery System Market by Disease: Cataract, 2021-2031, $ mn 63
Figure 36. North America Ophthalmic Drug Delivery System Market by Disease: Dry Eye Syndrome, 2021-2031, $ mn 64
Figure 37. North America Ophthalmic Drug Delivery System Market by Disease: Macular Degeneration, 2021-2031, $ mn 65
Figure 38. North America Ophthalmic Drug Delivery System Market by Disease: Diabetic Macular Edema, 2021-2031, $ mn 66
Figure 39. North America Ophthalmic Drug Delivery System Market by Disease: Refractive Issues, 2021-2031, $ mn 67
Figure 40. North America Ophthalmic Drug Delivery System Market by Disease: Other Diseases, 2021-2031, $ mn 68
Figure 41. Breakdown of North America Ophthalmic Drug Delivery System Market by Setting, 2021-2031, % of Revenue 70
Figure 42. North America Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 70
Figure 43. North America Ophthalmic Drug Delivery System Market by Setting: Hospitals, 2021-2031, $ mn 71
Figure 44. North America Ophthalmic Drug Delivery System Market by Setting: Clinics, 2021-2031, $ mn 72
Figure 45. North America Ophthalmic Drug Delivery System Market by Setting: Homecare Settings, 2021-2031, $ mn 73
Figure 46. North America Ophthalmic Drug Delivery System Market by Setting: Ambulatory Surgical Centers (ASCs), 2021-2031, $ mn 74
Figure 47. North America Ophthalmic Drug Delivery System Market by Setting: Other Settings, 2021-2031, $ mn 75
Figure 48. Breakdown of North America Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 77
Figure 49. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 50. U.S. Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 80
Figure 51. Canada Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 83
Figure 52. Ophthalmic Drug Delivery System Market in Mexico, 2021-2031, $ mn 86
Figure 53. Growth Stage of North America Ophthalmic Drug Delivery System Industry over the Forecast Period 89
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
